Lung Cancer Newswire

Talc or Minocycline Pleurodesis May Aid managing malignant pleural effusion Management in Lung Cancer with ILD: Study

Researchers have found in a new study that Pleurodesis using talc or minocycline had potential as a treatment option for managing malignant pleural effusion (MPE) in patients with lung cancer complicated by interstitial lung disease (ILD). What is known …

The connection between air quality and lung cancer: Dr. Peter Lin

A Father’s Day gift: Great-grandfather beats lung cancer with help of robots

When Alan Lesk visited his internist for an annual checkup, he mentioned that he occasionally experienced some nasal discomfort. His doctor ordered the athletic, Delray Beach great-grandfather to get an MRI. It saved his life. Celebrating Father’s Day, …

New Hope for Lung Cancer: Scientists Develop Targeted Genetic Treatment

A novel nanoparticle delivery system may transform treatment for lung diseases by sending genetic therapies directly to damaged cells—safely and effectively. Credit: Stock Researchers have developed a lung-targeted nanoparticle delivery system for genetic …

Lung cancer puts new perspective on running for Duluth mom

DULUTH — Since being diagnosed with Stage 4 lung cancer in November 2024, running has taken on a new meaning for 37-year-old Caitlin Quinn of Duluth. A mother of three children between 2 and 7, running used to be a break from her family. It was a chance to …

New Nanoparticles Therapy for Patients with Lung Cancer, Cystic Fibrosis: Study Finds

New Delhi: For treating respiratory diseases, scientists have developed a new drug delivery system that transports genetic therapies directly to the lungs, opening possibilities for patients with conditions like lung cancer and cystic fibrosis. Findings …

Nine small health issues that might be an early sign of lung cancer

Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our …

US FDA approves Nuvation Bio's taletrectinib for treatment of advanced ROS1─positive non─small cell lung cancer

Nuvation Bio Inc, a global oncology company focused on tackling some of the toughest challenges in cancer treatment, announced that the US Food and Drug Administration (FDA) has approved Ibtrozi (taletrectinib) for the treatment of adult patients with …

‘It was quite shocking’: Machesney Park woman says lung cancer can impact anyone

MACHESNEY PARK, Ill. (WIFR) - When you walk into No Joke Martial Arts, you may find 48-year-old Machesney Park woman and former amateur kickboxing champion Leslie Stoll. In 2024, Stoll went to the doctor for a routine CT scan after an injury. There, her …

Updates in Shared Decision-Making in Lung Cancer Following ASCO 2025

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to Dr. Eric Singhi. He added that discussing potential clinical trials is also vital for this patient population; their bravery for participating …

Firefighters are at higher risk of lung cancer. Free screenings aim to catch it early.

Firefighters have a 58 percent higher risk of developing mesothelioma, according to New England Cancer Specialists. KENNEBUNK, Maine — Firefighters are trained to protect others in the face of danger, but free cancer screenings offered Friday in southern …

Lung cancer screening program marks milestone in E.Ky.

Health officials and cancer care leaders gathered on June 10, to mark the culmination of a two-year lung health initiative aimed at increasing early lung cancer detection across rural Appalachia. The initiative was a collaboration between Pikeville Medical …

What Should Patients With Lung Cancer Know After ASCO 2025?

Patients with lung cancer — whether it be non-small cell lung cancer or small cell lung cancer — may benefit from updates provided at the 2025 ASCO Annual Meeting. Dr. Prantesh Jain and Dr. Joshua K. Sabari sat down for in interview, in which Sabari hosted …

ROS1DERS UK takes rare lung cancer fight to Parliament

A newly launched UK charity for patients with a rare and aggressive form of lung cancer has met with MPs at the Houses of Parliament to expose critical gaps in diagnosis, treatment, and national awareness. ROS1+ lung cancer disproportionately affects young …

COPD, GERD Tied to Elevated Lung Cancer Risk Among Never-Smokers

Photo Credit: iStock.com/Mohammed Haneefa Nizamudeen Long-standing inflammatory disorders, including COPD and GERD, signal heightened risk for lung cancer among never-smokers, according to research. Among patients who have never smoked—“never-smokers”— …

Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025

During the 2025 ASCO Annual Meeting, key updates were shared across all of oncology, including across lung cancer care. These updates are important for patients to learn more about, as these new data are driving the future of their care and changing the …

FDA Approves Ibtrozi for ROS1-Positive Lung Cancer

On June 11, the Food and Drug Administration approved Ibtrozi (taletrectinib) for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC). In two clinical trials, about 90% of patients not previously treated with this …

Qure.ai Introduces Lung Cancer AI Training

June 11, 2025 — To prepare healthcare workforces and providers for an AI-driven future, Qure.ai has expanded its Global AI Super User Training, to the United States. It has received approval from the American Society of Radiologic Technologists (ASRT). The …

‘Humor is a big part of it': Stanford's Dr. Bryant Lin on living with lung cancer

This weekend is graduation at Stanford. The keynote for Saturday's medical school ceremony is a Stanford doctor, professor and now patient. Dr. Bryant Lin is fighting stage four lung cancer. "Eventually got an X-ray, big white area here in my …

Dr. Kevin Sadati Present his Preservation Facelift Technique at Vegas Cosmetic Surgery and UC Irvine

“Preservation isn’t just a buzzword,” said Dr. Sadati. “It’s a guiding principle. NEWPORT BEACH, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- This week, facial plastic surgeon Dr. Kevin Sadati continued to gain national attention for …

CPR Classes Near Me Brings Premier CPR and First Aid Training to the Philadelphia Area

LANSDALE, PA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a leading provider of certified CPR and First Aid training, has expanded into the Philadelphia region with the opening of a new training center located at 5 N …

CPR Classes Near Me Opens New Location in Miami Lakes to Serve Hialeah and Surrounding Areas

MIAMI LAKES, FL, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a nationally trusted provider of American Heart Association (AHA) CPR and First Aid certification, has opened its newest location at 6625 Miami Lakes Dr #101 …

CPR Classes Near Me Launches 31st Location in Louisville, KY – Offering AHA Certification for Individuals and Businesses

LOUISVILLE, KY, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, a national leader in CPR and First Aid certification, is proud to announce the opening of its 31st training center, now open in Louisville at 1860 Mellwood …

CPR Classes Near Me Expands to 32nd Location in Boston Area – Now Open in Needham, MA

NEEDHAM, MA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- CPR Classes Near Me, one of the nation’s fastest-growing providers of CPR and First Aid certification, is proud to announce the opening of its 32nd training center, now serving the …

ClearView Imaging Center offering free heart scans

Free Heart Artery Calcium Score For All Patients THE VILLAGES, FL, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- ClearView Imaging Center is proud to announce the grand opening of its state-of-the-art diagnostic imaging facility at 3325 …

Mindworks NLP Offers a Smoking Cessation Group Hypnosis Live Event in Bellevue – June 21

Mindworks NLP announces a public group hypnosis seminar on June 21 to help participants quit smoking using powerful subconscious change techniques. BELLEVUE, WA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- In a time when public health and …

Redefining Fabry Disease Care: Gene Therapy and Long-Acting ERT Prepare to Disrupt Status Quo | Competitive Intellignece

Fabry disease treatment is advancing rapidly with gene therapies and next-gen ERTs promising durable efficacy, reduced burden, and broader mutation coverage. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Fabry Disease, a rare, X …

Rewriting the Playbook in MPS I: CNS-Penetrant ERTs and Gene Therapies Usher in a New Treatment Era | CI Insights

Emerging CNS‑targeting ERTs and gene therapies for MPS I show promise for neurocognitive benefits, reduced treatment burden, and better outcomes. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Mucopolysaccharidosis type I (MPS I) …

Hunter Syndrome Therapeutics Evolve: Novel CNS-Targeting Therapies Set to Challenge Elaprase’s Market Monopoly

New CNS-penetrant therapies and gene therapies are poised to transform the Hunter Syndrome landscape, ending Elaprase’s long-standing treatment dominance. AUSTIN, TX, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Hunter Syndrome ( …

Thorncrest Dental Brings Advanced Laser Dentistry to Etobicoke with Picasso Soft Tissue Laser

ETOBICOKE, ONTARIO, CANADA, June 15, 2025 /⁨EINPresswire.com⁩/ -- Thorncrest Dental is proud to introduce the Picasso Soft Tissue Laser, a cutting-edge addition to its suite of dental technologies, now available to patients in the Etobicoke community. This …

Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal ...

EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study New late-breaking data at EAACI showed Dupixent …

Communiqué : Dupixent a démontré sa supériorité par rapport au Xolair dans la rhinosinusite chronique avec polypes ...

EAACI : Le Dupixent a démontré sa supériorité par rapport au Xolair (omalizumab) dans la rhinosinusite chronique avec polypes nasaux chez des patients atteints d’asthme coexistant dans la toute première étude respiratoire de phase 4 en comparaison directe …

Dupixent® (dupilumab) Demonstrated Superiority Over Xolair® (Omalizumab) in Chronic Rhinosinusitis with Nasal Polyps (...

New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints Dupixent also outperformed Xolair in improving such key signs and symptoms as nasal polyp …

Tom Jackobs Offers Fractional Sales Management for Heart-Led Wellness Practices

New service helps mission-driven businesses improve sales performance without building a full in-house sales team. LOS ANGELES, CA, UNITED STATES, June 15, 2025 /⁨EINPresswire.com⁩/ -- Tom Jackobs, international sales strategist, is now offering …

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in ...

With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up, …

New national report reveals critical gaps in asthma and COPD care

A new NRAP report has highlighted persistent and widespread gaps in the care of people with asthma and chronic obstructive pulmonary disease (COPD) across England and Wales, calling on integrated care boards and local health boards to mandate all eligible …

RCP statement on Air India crash

RCP president, Dr Mumtaz Patel, said: ‘We are devastated by the plane crash in India today and the many lives it has claimed. Our thoughts and prayers are with everyone affected by this tragic incident. ‘We are directly contacting all our RCP members in …

Latest ‘Focus on physicians’ survey closes with over 2000 responses from doctors across the UK

The 2025 ‘Focus on physicians’ survey – a joint project between the Royal College of Physicians (RCP), the Royal College of Physicians and Surgeons of Glasgow (RCPSG) and the Royal College of Physicians of Edinburgh (RCPE) – has now closed. The ‘Focus on …

Translational Data Illustrate a Mechanism of Greater Potency with Verekitug, a Novel Antibody Antagonist of the TSLP ...

– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to tezepelumab – – Supports potentially differentiated profile of …